UB Paderborn / Katalog / Suche / in CDI

Direct-to-consumer testing: more risks than opportunities

International journal of clinical practice (Esher), 2011-12, Vol.65 (12), p.1221-1229

2011

Volltextzugriff (PDF)

Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.198-210

2018

Volltextzugriff (PDF)

Utility of the PFA-100® for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations

Haemophilia : the official journal of the World Federation of Hemophilia, 2001-03, Vol.7 (2), p.170-179

Favaloro, E. J.

2001

Volltextzugriff (PDF)

Evaluation of a new commercial von Willebrand factor multimer assay

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.e373-e377

2017

Volltextzugriff (PDF)

Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source

Thrombosis and haemostasis, 2000-01, Vol.83 (1), p.127-135

Favaloro, E J

2000

Volltextzugriff (PDF)

The Platelet Function Analyser (PFA)-100 and von Willebrand disease: a story well over 16 years in the making

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.642-645

Favaloro, E. J.

2015

Volltextzugriff (PDF)

Mild hemophilia A

Journal of thrombosis and haemostasis, 2010-03, Vol.8 (3), p.421-432

2010

Volltextzugriff (PDF)

Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (s4), p.66-72

2012

Volltextzugriff (PDF)

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

Journal of thrombosis and haemostasis, 2006-10, Vol.4 (10), p.2103-2114

2006

Volltextzugriff (PDF)

Genetic testing for von Willebrand disease: the case against

Journal of thrombosis and haemostasis, 2010-01, Vol.8 (1), p.6-12

FAVALORO, E. J.

2010

Volltextzugriff (PDF)

Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants

International journal of laboratory hematology, 2013-06, Vol.35 (3), p.269-274

Favaloro, E. J.

2013

Volltextzugriff (PDF)

Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2016-02, Vol.14 (2), p.411-414

2016

Volltextzugriff (PDF)

Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (4), p.662-670

2010

Volltextzugriff (PDF)

The increasing maturity of the von Willebrand factor collagen binding in von Willebrand disease diagnosis

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.20-23

2018

Volltextzugriff (PDF)

Laboratory testing for factor inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (s4), p.94-98

2014

Volltextzugriff (PDF)

Type 2M von Willebrand disease - more often misidentified than correctly identified

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.e145-e155

2016

Volltextzugriff (PDF)

Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2842-2844

2010

Volltextzugriff (PDF)

Management of pregnancy complications in type 2N von Willebrand disease associated to a novel mutation

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.e148-e152

2018

Volltextzugriff (PDF)

Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2828-2831

2010

Volltextzugriff (PDF)

Differential sensitivity of von Willebrand factor (VWF) ‘activity’ assays to large and small VWF molecular weight forms: a cross‐laboratory study comparing ristocetin cofactor, collagen‐binding and mAb‐based assays

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1043-1054

2012

Volltextzugriff (PDF)

Pearls and pitfalls in factor inhibitor assays

International journal of laboratory hematology, 2015-05, Vol.37 (S1), p.52-60

2015

Volltextzugriff (PDF)

Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand’s disease

Blood reviews, 1999-12, Vol.13 (4), p.185-204

Favaloro, E.J.

1999

Volltextzugriff (PDF)

Diagnosis of type 1 vs. 2A and 2M von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.e9-e11

FAVALORO, E. J.

2012

Volltextzugriff (PDF)

Template bleeding time and PFA‐100® have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients – a rebuttal

Journal of thrombosis and haemostasis, 2004-12, Vol.2 (12), p.2280-2282

FAVALORO, E. J.

2004

Volltextzugriff (PDF)

von Willebrand disease and platelet disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (s4), p.59-64

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Direct-to-consumer testing: more risks than opportunities

Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease

Utility of the PFA-100® for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations

Evaluation of a new commercial von Willebrand factor multimer assay

Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source

The Platelet Function Analyser (PFA)-100 and von Willebrand disease: a story well over 16 years in the making

Mild hemophilia A

Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

Genetic testing for von Willebrand disease: the case against

Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants

Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH

Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia

The increasing maturity of the von Willebrand factor collagen binding in von Willebrand disease diagnosis

Laboratory testing for factor inhibitors

Type 2M von Willebrand disease - more often misidentified than correctly identified

Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay

Management of pregnancy complications in type 2N von Willebrand disease associated to a novel mutation

Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required

Differential sensitivity of von Willebrand factor (VWF) ‘activity’ assays to large and small VWF molecular weight forms: a cross‐laboratory study comparing ristocetin cofactor, collagen‐binding and mAb‐based assays

Pearls and pitfalls in factor inhibitor assays

Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand’s disease

Diagnosis of type 1 vs. 2A and 2M von Willebrand disease

Template bleeding time and PFA‐100® have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients – a rebuttal

von Willebrand disease and platelet disorders

Suchergebnisse filtern